It is, of course, Mamma Mia. The timeless tale of young Sophie who is preparing to wed (the very hunky) Sky, but sneakily invites her three potential fathers to the Greek island, much to the surprise ...

This season's Rusical is inspired by a mashup of the classical Broadway musical Annie and NYC ballroom culture in a new episode of "RuPaul’s Drag Race." ...

The letter featuring the drawings had previously been sent to Beatrice Stillman, who joined the royal household in 1936, when the Queen was around 10 years old Becca Longmire is a digital news ...

Feb 15 10:45 AM Tufts vs. Pennsylvania (Women’s Final) Broadcast live on Ultiworld Feb 15 10:45 AM North Carolina vs. Chicago (Men’s Final) Broadcast live on Ultiworld Feb 15 9:00 AM North Carolina vs ...

NEIGHBORS IN KANSAS AND MISSOURI. KANSAS CITY’S NEWS LEADER KMBC NINE NEWS. IT’S A DAVID VERSUS GOLIATH STORY THAT’S CONNECTING THE COMMUNITY TO A 108 YEAR OLD CANDY COMPANY. DAVID IS THE SAINT JOSEPH ...

The fifth release of the ultra-rare expression draws from seven barrels aged up to three decades—proving that in today’s top tier, composition matters more than age alone. When Michter’s Master of ...

Associate Editor Casey Epstein-Gross’s column Cultural Reset features regular deep dives into the impact of music on culture—and vice versa—in the 21st century from the perspective of someone born and ...

Disneyland Cast Members are the ones who make the magic happen daily at the Happiest Place on Earth. Great Cast Members are doing great work every day, but most of the time, the people getting the ...

Madrigal Pharma was the first drugmaker to bring a treatment for metabolic dysfunction-associated steatohepatitis (MASH) to market, and has now signed a major alliance with China's Ribo Life Science ...

Ultiworld’s 2026 college coverage is presented by Spin Ultimate; all opinions are those of the author(s). Find out how Spin can get you, and your team, looking your best this season. One of the main ...

The pact between Madrigal Pharmaceuticals and Ruzhou Ribo Life Sciences could complement the former’s Rezdiffra, the first FDA-approved therapy for MASH. That drug made $287.3 million in the third ...

The potentially $4.4 billion deal is Madrigal’s second with a China-based biotech and hands the company six preclinical RNA interference medicines for the common liver condition. Madrigal surprised ...